Intelligence / Healthtech / New Clinical Trials
ClinicalLIVEUpdated 18 Nov 2026
New Clinical Trials
Clinical trials companies registered in the last 30 days, worldwide, with the sponsor, phase and countries.
Sources: ClinicalTrials.gov · Rebuilt weekly · Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase.
Trials
777
in the 30 days to 2026-11-18
Added in 30 days
777
to 18 Nov 2026
Top country
United States
192 · 25% of the list
Phase covered
8
distinct values
Snapshot · 18 Nov 2026
Explore all 777 Growth
By month
777
Signals
What the register says this week, and why it matters if you sell into it.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
- 174 of the listed studies are device, diagnostic or digital-health studies (no drug phase).
- A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
PostedSponsorStudyPhaseStatus
22 Oct 2026Lumosa Therapeutics Co., Ltd.TaiwanA Study to Evaluate the Intracranial Arterial Recanalization With Multiple Doses of LT3001 Drug Product in AIS ParticipantPhase 2Recruiting22 Oct 2026Novartis PharmaceuticalsManaged Access Programs for MAS825, ArumakimigTemporarily Not Available22 Oct 2026Pathalys PharmaUnited StatesA Study of PLS240 in Pediatric Participants With Secondary Hyperparathyroidism and Chronic Kidney Disease on HemodialysisPhase 3Not Yet Recruiting22 Oct 2026PfizerA Study of a Medicine Called Atirmociclib in Combination With Giredestrant in Adult Participants With ER-positive, HER2-negative Early-stage Breast CancerPhase 3Not Yet Recruiting22 Oct 2026Pharmasaga Co. Ltd.A Phase 2 Two-Part Study of Oral PS1 in Healthy Volunteers and Adults With Newly Diagnosed Type 1 DiabetesPhase 2Not Yet Recruiting22 Oct 2026SanofiPolandStudy of a Combination SARS-CoV-2 Recombinant Spike and High-Dose Inactivated Influenza Vaccine With Matrix-M Adjuvant in Adult Participants 60 Years of Age and OlderPhase 3Recruiting22 Oct 2026ScandiBio Therapeutics ABTurkey (Türkiye)Combined Metabolic Activator Supplementation in Subjects Diagnosed With GoutPhase 3Not Yet Recruiting22 Oct 2026Serum Institute of India Pvt. Ltd.AustraliaClinical Trial to Assess the Safety, Tolerability, Reactogenicity, and Immunogenicity of a 10 Valent Human Papillomavirus Virus (10vHPV) VaccinePhase 1, Phase 2Not Yet Recruiting22 Oct 2026Sinovac Biotech Co., LtdChinaPhase I Clinical Trial of Trivalent Inactivated Split Influenza Virus Vaccine (MDCK Cell)Phase 1Not Yet Recruiting22 Oct 2026Sinovac Biotech Co., LtdChinaStudy on the Long-Term Persistence of Immunity Induced by Inactivated Hepatitis A VaccineRecruiting22 Oct 2026SPH Sine Pharmaceutical Laboratories Co., Ltd.ChinaWST03 Capsule Combined With Metronidazole for Bacterial VaginosisPhase 2Not Yet Recruiting22 Oct 2026Terumo Europe N.V.Austria, Belgium, GermanyEvaluation of Safety, Performance and Usability of the TR Band DISTAL Device for Hemostasis Following Distal Radial Access in Coronary ProceduresNot Yet Recruiting22 Oct 2026Therabody, Inc.United StatesEfficacy of an LED MaskNot applicableEnrolling By Invitation22 Oct 2026Vertex Pharmaceuticals IncorporatedUnited StatesA Phase 3b Study of Participant Experience on Povetacicept Administered Via Autoinjector as Compared to Sibeprenlimab Administered Via Prefilled SyringePhase 3Recruiting21 Oct 2026Antido Therapeutics (Australia) Pty LtdAustraliaSafety and Tolerability of AT-0174 in Adults With Advanced Solid TumorsPhase 1Completed21 Oct 2026Ausper Biopharma Co., Ltd.ChinaA Clinical Study of AHB-121 in Healthy Participants and Chronic Hepatitis B (CHB) ParticipantsPhase 1Not Yet Recruiting21 Oct 2026Azafaros B.V.Long-Term Safety and Tolerability of Nizubaglustat in Participants With Rare Lysosomal DisordersPhase 2, Phase 3Not Yet Recruiting21 Oct 2026BeOne MedicinesA Study Investigating the Safety and How the Trispecific T-Cell Engaging Antibody BG-T0920 Works in Adults With Diffuse Large B-cell Lymphoma (DLBCL) and Other Aggressive B-Cell MalignanciesPhase 1Not Yet Recruiting21 Oct 2026BiogenA Study to Learn More About Friedrich's Ataxia in People Living in the Gulf Cooperation Council (GCC) Region of the WorldNot Yet Recruiting21 Oct 2026BioNTech SEA Clinical Trial to Test if the Investigational Drug BNT3210 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker Sialyl-TnPhase 1, Phase 2Not Yet Recruiting21 Oct 2026Bristol-Myers SquibbUnited StatesA Phase 1 Study to Evaluate Safety, Tolerability, and Drug Levels of BMS-986485 in Healthy Adult ParticipantsPhase 1Not Yet Recruiting21 Oct 2026Clinical Nutrition Research Center, Illinois Institute of TechnologyUnited StatesDifferential Absorption Kinetics of Grape Seed Extract PolyphenolsNot applicableNot Yet Recruiting21 Oct 2026Clinical Nutrition Research Center, Illinois Institute of TechnologyUnited StatesEffects of Mango on Insulin Sensitivity in PrediabetesNot applicableNot Yet Recruiting21 Oct 2026Ethyreal Bio, Inc.United StatesEvaluation of ETHY-001 for Safety, Tolerability, and Clinical Activity in Thyroid Eye DiseasePhase 1Recruiting21 Oct 2026FASTENFranceFasten Onco Digital Therapy During Neoadjuvant Treatment for Triple-Negative Breast CancerNot applicableNot Yet Recruiting21 Oct 2026GRIN Therapeutics, Inc.United StatesA Study to Evaluate the Effect of Carbamazepine or Itraconazole on Radiprodil in Healthy Adult ParticipantsPhase 1Active Not Recruiting21 Oct 2026Imagion Biosystems, Inc.United StatesMagSense® Human Epidermal Growth Factor Receptor 2 (HER2) Imaging Agent (MSH2IA)Phase 1, Phase 2Recruiting21 Oct 2026Innovent Biologics (Suzhou) Co. Ltd.ChinaIBI3034 Study in Healthy Adults and Patients With Primary IgA NephropathyPhase 1Not Yet Recruiting21 Oct 2026InnSight Technology, Inc.United StatesCorneal Trauma Diagnostic StudyNot applicableRecruiting21 Oct 2026IRulya Therapeutics Inc.United StatesLAM-001 for the Treatment of Sarcoidosis Associated Pulmonary Hypertension (SAPH)Phase 2Not Yet Recruiting21 Oct 2026iVascular S.L.U.iLITE, Clinical Performance of the Angiolite™ Drug-Eluting StentNot Yet Recruiting21 Oct 2026Jiangsu Hansoh Pharmaceutical Co., Ltd.ChinaA Study of HS-10382 Versus Investigator-selected TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CPPhase 3Not Yet Recruiting21 Oct 2026KingdomUnited StatesA Fifth Proof-of-Concept Study to Evaluate the Efficacy of NOBO, a Novel Postbiotic, in Controlling Axillary Odor in Healthy AdultsNot applicableActive Not Recruiting21 Oct 2026Kite, A Gilead CompanyA Trial to Evaluate Safety and Efficacy of Anitocabtagene Autoleucel Versus Standard of Care in Newly Diagnosed Multiple MyelomaPhase 3Not Yet Recruiting21 Oct 2026Lee's Pharmaceutical LimitedChinaStudy to Evaluate the Safety, Tolerability, and Pharmacokinetics of Recombinant Anfibatide Injection in Healthy VolunteersPhase 1Not Yet Recruiting21 Oct 2026PfizerA Study to Learn About the Study Medicine Abrocitinib in People With Severe Atopic Dermatitis Who Have Switched From Other TherapiesNot Yet Recruiting21 Oct 2026PfizerA Study to Learn About Revaccination With a Vaccine Called RSVpreF in Older AdultsPhase 3Not Yet Recruiting21 Oct 2026Prime Medicine, Inc.A Study of the Safety and Efficacy of Prime Editing (PM647a) in Participants With Alpha-1 Antitrypsin DeficiencyPhase 1, Phase 2Not Yet Recruiting21 Oct 2026Probi ABUnited KingdomEffects of Probiotics on Skin Health in Healthy WomenNot applicableNot Yet Recruiting21 Oct 2026Regeneron PharmaceuticalsREGN9220 in Combination With Odronextamab in Adult Participants With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphomas (BCNHLs)Phase 1, Phase 2Not Yet Recruiting21 Oct 2026ReValve Solutions Inc.The PALMETTO StudyNot applicableNot Yet Recruiting21 Oct 2026Synbalance S.r.l.ItalyProbiotic Supplement for Recurrent UTIs in Healthy Women (L. Plantarum, L. Rhamnosus, B. Lactis)Not applicableActive Not Recruiting21 Oct 2026Tarsus Pharmaceuticals, Inc.United States, Dominican Republic, El SalvadorA Study to Evaluate the Efficacy and Safety of TP-06 for PCEDPhase 2Recruiting21 Oct 2026UNCANCER LLCUnited StatesOral Care Program for Mouth Side Effects During Head and Neck Radiation TherapyNot applicableRecruiting21 Oct 2026Vigonvita Life SciencesStudy of the Safety, Tolerability, Pharmacokinetics of VV147 Tablets in Chinese Healthy Participants.Phase 1Not Yet Recruiting21 Oct 2026WockhardtBosnia and Herzegovina, Bulgaria, CroatiaCefepime-Zidebactam Versus Ceftazidime-Avibactam With or Without Colistin for Hospital-Acquired or Ventilator-Associated Bacterial PneumoniaPhase 3Not Yet Recruiting20 Oct 2026a2 Milk Company Ltd.ChinaMilk Free From A1-Type β-Casein With Human Milk Oligosaccharides on Gut Health, Immunity, Cognitive Development, and Temperament in ToddlersNot applicableNot Yet Recruiting20 Oct 2026AkesoA Study to Evaluate the Efficacy and Safety of AK139 in Patients With Prurigo Nodularis.Phase 2Not Yet Recruiting20 Oct 2026Alfasigma S.p.A.ItalySTUDY OF THE EFFECTS OF L. CASEI DG® (ENTEROLACTIS BABY) IN HEALTHY PRETERM AND FULL-TERM INFANTS.Not applicableCompleted20 Oct 2026Ascilion ABGermanyMicroneedle-based ISF Sampling TechniqueNot applicableNot Yet Recruiting// How AOS uses this